ACAD
32.84
-0.51
-1.53%
AEMD
0.23
-0.01
-4.17%
APRI
1.94
+0.02
+1.04%
ARNA
4.44
-0.04
-0.89%
ATEC
1.41
0.00
0.00%
CNAT
7.32
-0.21
-2.79%
CRXM
0.195
0.00
0.00%
CYTX
1.185
-0.015
-1.250%
DXCM
62.825
+0.845
+1.363%
GNMK
13.22
-0.08
-0.60%
HALO
14.43
+0.43
+3.07%
ILMN
185.465
-2.155
-1.149%
INNV
0.179
0.00
0.00%
INO
8.19
-0.14
-1.68%
ISCO
0.059
+0.001
+0.855%
ISIS
64.92
+0.11
+0.17%
LGND
76.79
+0.56
+0.73%
LPTN
2.417
-0.054
-2.1660%
MBVX
1.86
0.00
0.00%
MEIP
1.79
+0.04
+2.29%
MNOV
3.43
-0.16
-4.46%
MRTX
28.25
-0.86
-2.95%
MSTX
0.488
-0.01
-1.9297%
NBIX
39.75
-1.78
-4.29%
NUVA
46.14
-0.26
-0.56%
ONCS
0.33
-0.02
-5.71%
ONVO
3.407
+0.037
+1.098%
OREX
7.87
+0.12
+1.55%
OTIC
34.501
-1.13
-3.1701%
QDEL
27.02
-0.48
-1.7451%
RCPT
164.5
+4.45
+2.78%
RGLS
17.2
-0.06
-0.35%
RMD
71.92
+0.27
+0.38%
SCIE
0.03
0.00
+17.65%
SPHS
0.58
+0.03
+5.4182%
SRNE
11.745
+0.385
+3.389%
TROV
6.92
-0.08
-1.14%
VICL
0.935
+0.035
+3.9000%
VOLC
17.99
0.00
0.00%
ZGNX
1.38
+0.01
+0.73%
ACAD
32.84
-0.51
-1.53%
AEMD
0.23
-0.01
-4.17%
APRI
1.94
+0.02
+1.04%
ARNA
4.44
-0.04
-0.89%
ATEC
1.41
0.00
0.00%
CNAT
7.32
-0.21
-2.79%
CRXM
0.195
0.00
0.00%
CYTX
1.185
-0.015
-1.250%
DXCM
62.825
+0.845
+1.363%
GNMK
13.22
-0.08
-0.60%
HALO
14.43
+0.43
+3.07%
ILMN
185.465
-2.155
-1.149%
INNV
0.179
0.00
0.00%
INO
8.19
-0.14
-1.68%
ISCO
0.059
+0.001
+0.855%
ISIS
64.92
+0.11
+0.17%
LGND
76.79
+0.56
+0.73%
LPTN
2.417
-0.054
-2.1660%
MBVX
1.86
0.00
0.00%
MEIP
1.79
+0.04
+2.29%
MNOV
3.43
-0.16
-4.46%
MRTX
28.25
-0.86
-2.95%
MSTX
0.488
-0.01
-1.9297%
NBIX
39.75
-1.78
-4.29%
NUVA
46.14
-0.26
-0.56%
ONCS
0.33
-0.02
-5.71%
ONVO
3.407
+0.037
+1.098%
OREX
7.87
+0.12
+1.55%
OTIC
34.501
-1.13
-3.1701%
QDEL
27.02
-0.48
-1.7451%
RCPT
164.5
+4.45
+2.78%
RGLS
17.2
-0.06
-0.35%
RMD
71.92
+0.27
+0.38%
SCIE
0.03
0.00
+17.65%
SPHS
0.58
+0.03
+5.4182%
SRNE
11.745
+0.385
+3.389%
TROV
6.92
-0.08
-1.14%
VICL
0.935
+0.035
+3.9000%
VOLC
17.99
0.00
0.00%
ZGNX
1.38
+0.01
+0.73%
Home » Events

San Diego Biotech Discussion Group Biotalk

Submitted by on July 15, 2009 – 1:12 pm

“Tumor Targeting with Nanoparticles”
Marit Piacente, DVM – Head of Preclinical Development, Abraxis

July 29, 2009
5:30 – 8:00 pm
(Announcements begin at 6:30 pm)

AT SORRENTO SUMMIT

[[Click here for more information.]]

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


× one = 2